These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11827917)

  • 1. Angiographical follow-up after radioactive "Cold Ends" stent implantation: a multicenter trial.
    Wardeh AJ; Albiero R; Kay IP; Knook AH; Wijns W; Kozuma K; Nishida T; Ferrero V; Levendag PC; van Der Giessen WJ; Colombo A; Serruys PW
    Circulation; 2002 Feb; 105(5):550-3. PubMed ID: 11827917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and angiographical follow-up after implantation of a 6--12 microCi radioactive stent in patients with coronary artery disease.
    Wardeh AJ; Knook AH; Kay IP; Sabaté M; Coen VL; Foley DP; Hamburger JN; Levendag PC; van der Giessen WJ; Serruys PW
    Eur Heart J; 2001 Apr; 22(8):669-75. PubMed ID: 11286524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Particle-emitting radioactive stent implantation. A safety and feasibility study.
    Wardeh AJ; Kay IP; Sabaté M; Coen VL; Gijzel AL; Ligthart JM; den Boer A; Levendag PC; van Der Giessen WJ; Serruys PW
    Circulation; 1999 Oct; 100(16):1684-9. PubMed ID: 10525486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European high-activity (32)P radioactive stent experience.
    Albiero R; Colombo A
    J Invasive Cardiol; 2000 Aug; 12(8):416-21. PubMed ID: 10953106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Edge Effect" of (32)p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff.
    van Der Giessen WJ; Regar E; Harteveld MS; Coen VL; Bhagwandien R; Au A; Levendag PC; Ligthart J; Serruys PW; den Boer A; Verdouw PD; Boersma E; Hu T; van Beusekom HM
    Circulation; 2001 Oct; 104(18):2236-41. PubMed ID: 11684637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: The Milan Dose-Response Study.
    Albiero R; Adamian M; Kobayashi N; Amato A; Vaghetti M; Di Mario C; Colombo A
    Circulation; 2000 Jan 4-11; 101(1):18-26. PubMed ID: 10618299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia.
    Kay IP; Wardeh AJ; Kozuma K; Foley DP; Knook AH; Thury A; Sianos G; van der Giessen WJ; Levendag PC; Serruys PW
    Circulation; 2001 Jan; 103(1):14-7. PubMed ID: 11136678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents.
    Albiero R; Nishida T; Adamian M; Amato A; Vaghetti M; Corvaja N; Di Mario C; Colombo A
    Circulation; 2000 May; 101(21):2454-7. PubMed ID: 10831516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of radioactive stents for the prevention of in-stent restenosis.
    Carter AJ; Fischell TA
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):127-33. PubMed ID: 9588927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the "candy-wrapper" effect of (32)P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasound.
    Hansen A; Hehrlein C; Hardt S; Bekeredjian R; Brachmann J; Kubler W; Bode C; Kuecherer HF
    Catheter Cardiovasc Interv; 2001 Sep; 54(1):41-8. PubMed ID: 11553946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta brachytherapy of an old degenerated saphenous vein graft with occlusive in-stent restenosis.
    Ortolani P; Marzocchi A; Gaiba W; Neri S; Marrozzini C; Palmerini T; Aquilina M; Branzi A
    Ital Heart J; 2003 Sep; 4(9):646-50. PubMed ID: 14635385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antioxidant probucol for preventing stent restenosis.
    Kim MH; Cha KS; Han JY; Kim HJ; Kim JS
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):424-8. PubMed ID: 12455074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE).
    Serruys PW; Wijns W; Sianos G; de Scheerder I; van den Heuvel PA; Rutsch W; Glogar HD; Macaya C; Materne PH; Veldhof S; Vonhausen H; Otto-Terlouw PC; van der Giessen WJ
    J Am Coll Cardiol; 2004 Aug; 44(3):528-37. PubMed ID: 15358015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular brachytherapy in coronary arteries: the Rotterdam experience.
    Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ; De Pan C; Sipkema D; Marijnissen JP; Sabaté M; den Boer A; Serruys PW; Levendag PC
    Cardiovasc Radiat Med; 2000; 2(1):42-50. PubMed ID: 11229062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response effects of 32P radioactive stents in an atherosclerotic porcine coronary model.
    Carter AJ; Scott D; Bailey L; Hoopes T; Jones R; Virmani R
    Circulation; 1999 Oct; 100(14):1548-54. PubMed ID: 10510059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation.
    Kay IP; Wardeh AJ; Kozuma K; Sianos G; Regar E; Knook M; van der Giessen WJ; Thury A; Ligthart JM; Coen VM; Levendag PC; Serruys PW
    Eur Heart J; 2001 Aug; 22(15):1311-7. PubMed ID: 11465963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients.
    Babalik E; Gürmen T; Orhan L; Bulur H; Gülbaran M; Ersanli M; Oztürk S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):306-12. PubMed ID: 12594693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of a novel balloon-expandable gamma-emitting ((103)Pd) stent to prevent edge effects.
    Hehrlein C; DeVries JJ; Arab A; Haller SD; Schloesser K; Tio FO; Fischell TA
    Circulation; 2001 Nov; 104(19):2358-62. PubMed ID: 11696478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results.
    Gercken U; Lansky AJ; Buellesfeld L; Desai K; Badereldin M; Mueller R; Selbach G; Leon MB; Grube E
    Catheter Cardiovasc Interv; 2002 Jul; 56(3):353-60. PubMed ID: 12112888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.